Advertisement

Life-Sciences-Asia.com
The East-West Life Sciences Web Portal
This is a free web portal for the life sciences in Asia-Pacific, Europe and North America... » read more
- Nuclidium Closes CHF79m Series B Financing Round (2025-07-10)
> Proceeds will fund further clinical development of the company’s true theranostic pipeline and expansion of the global production and manufacturing network for copper-based radiopharmaceuticals. > Initial clinical data presented at SNMMI 2025 by Dr. Gary Ula... - Idorsia: Simcere Receives Approval for Quviviq in China (2025-06-23)
Idorsia to receive USD 50 million (an additional USD 30 million) approval milestone payment in return for a reduction in Simcere potential sales milestones and tiered royalty payments. Ad hoc announcement pursuant to Art. 53 LR Idorsia Ltd. (SIX: IDIA) to... - UK NICE Rejects NHS Coverage for Two New Alzheimer Drugs (2025-06-19)
The benefits from donanemab (also called Kisunla and made by Eli Lilly) and lecanemab (also called Leqembi and made by Eisai) - remain too small to justify the additional cost to the NHS, one of our independent committees has concluded following consultation. ... - Sphere Bio Expands Operations in China (2025-06-17)
> Exclusive agreement with specialist biotechnology distributor, Redbert Biotechnology, to strengthen international growth and market penetration. > Johnathan Fu appointed as Country Manager to lead regional partnerships and enhance customer support. [photo... - Arima Genomics Raises $22m Series C; Appoints New CEO (2025-06-17)
llumina Ventures leads round to accelerate Arima’s clinical expansion Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced the appointment of T... - AstraZeneca: up to $5,33b Strategic Collaboration with CSPC (2025-06-13)
AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group Limited. Working together on high priority targets, the collaboration aims to advance the discovery and development of novel oral candidates, with the... - BioNTech to Acquire CureVac for $1.25b in Shares (2025-06-12)
> Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key milestone in the execution of its oncology strategy > Acquisition of CureVac will comple... - Deep Apple Therapeutics and Novo Nordisk: up to $812m (2025-06-11)
> Partnership aims to develop first-in-class, small molecule therapeutics directed at a novel non-incretin GPCR target for cardiometabolic diseases > Deep Apple is eligible to receive up to $812 million, including an upfront payment, research costs, and mileston... - Mosanna Therapeutics Launches with $80m Series A Round (2025-06-09)
> Series A funding to advance MOS118 through Phase 2 clinical trials > Biotech veteran David Weber appointed CEO to drive clinical development > Obstructive sleep apnea affects nearly 1 billion people globally, with the majority undiagnosed and underserved wi... - BioNTech & BMS: up to $11.1b for Bispecific Antibody BNT327 (2025-06-02)
> BNT327, BioNTech’s PD-L1xVEGF-A bispecific antibody, is a clinically advanced investigational immunotherapy candidate with the potential to surpass current checkpoint inhibitor outcomes and set a new standard of care in multiple tumor types > The co-developm...
Life-Sciences-Asia.com is your doorway to the East-West life sciences!
[LSA] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the Asia-Pacific, Europe and North America regions.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Europe!
» Start here with the latest News!Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top